Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
about
New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformaticsInformatics and standards for nanomedicine technologyThe Use of Synthetic Carriers in Malaria Vaccine DesignNanoparticles Biosynthesized by Fungi and Yeast: A Review of Their Preparation, Properties, and Medical ApplicationsRecommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging fieldOverview about the localization of nanoparticles in tissue and cellular context by different imaging techniquesNeuroantibody biomarkers: links and challenges in environmental neurodegeneration and autoimmunityNanoparticles for biomedical imaging: fundamentals of clinical translationProcessing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolyticBioavailability, intracellular mobilization of nickel, and HIF-1α activation in human lung epithelial cells exposed to metallic nickel and nickel oxide nanoparticlesInteractions of engineered nanomaterials in physiological media and implications for in vitro dosimetryA novel platform for pulmonary and cardiovascular toxicological characterization of inhaled engineered nanomaterialsHow toxic are gold nanoparticles? The state-of-the-artGenotoxicity and Cytotoxicity of Cadmium Sulfide Nanomaterials to Mice: Comparison Between Nanorods and Nanodots.Molecular recognition by gold, silver and copper nanoparticles.Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.Gold nanoparticles in biology and medicine: recent advances and prospects.Molecular imaging: current status and emerging strategies.Acidic pH-targeted chitosan capped mesoporous silica coated gold nanorods facilitate detection of pancreatic tumors via multispectral optoacoustic tomographyA review of the applications of data mining and machine learning for the prediction of biomedical properties of nanoparticles.Size and shape distributions of primary crystallites in titania aggregates.Biomedical applications of nanotechnology.Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres.25th anniversary article: interfacing nanoparticles and biology: new strategies for biomedicine.Uptake and intracellular localization of submicron and nano-sized SiO₂ particles in HeLa cells.Palladium: a future key player in the nanomedical field?Cell Microarray Technologies for High-Throughput Cell-Based Biosensors.Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation.Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical applicationSize and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot-lipid complex.Recent applications of carbon-based nanomaterials in analytical chemistry: critical reviewBiodistribution and in vivo toxicity of aptamer-loaded gold nanostars.Biocompatibility of bio based calcium carbonate nanocrystals aragonite polymorph on NIH 3T3 fibroblast cell line.Promotion of allergic immune responses by intranasally-administrated nanosilica particles in mice.125I-labeled gold nanorods for targeted imaging of inflammation.Public optimism towards nanomedicine.Gold nanorods as a theranostic platform for in vitro and in vivo imaging and photothermal therapy of inflammatory macrophages.Titanium dioxide nanoparticles in food and personal care products.Titanates and Titanate-Metal Compounds in Biological Contexts
P2860
Q23910479-4BC80AA0-E372-4E05-A6F0-A312ED6B0B79Q23912034-0D14A76D-15F8-4770-A8F0-8968C64CAB5DQ26777053-FDA38F2A-966B-42F7-BB47-E73E06A98655Q26785984-DAE873D1-A05B-4DE8-B6E9-2A8B6E725DDEQ26822431-C9B70E75-003C-4985-975C-7972B8BFDD01Q26853219-86B33A90-EAE6-43F0-907B-731C83AC10D5Q27010245-A11F195C-976C-458C-ACBD-444D68834FC8Q28385644-33942F27-1C74-467A-AF4C-11C3BF14C715Q28391345-160ED851-F70E-4C9A-96BE-3ECC5325ECA1Q28392810-5B7EAB25-E9D2-44AF-8258-F6D9C8B677F5Q28397068-99DABC31-3BFF-4AA3-8D03-A44E1C8DF6A9Q28397581-042A8B96-D8C2-4702-AB2A-37134756F7B0Q29306855-9F215236-F6FB-417C-B0CB-A0FFFD11E5DFQ30388290-D3E3491C-E1A7-4F5A-AD6E-225A20A7FEC8Q30450339-84108A94-27AE-492D-A3FD-AFC1EB23C225Q30465367-A060CC0D-47AD-474E-BB0E-DC10A604B60BQ30467305-5E2167A5-1ADF-4C38-A34B-219734F87743Q30474579-03BE3BE6-31C9-4E37-9E3C-556F01436D26Q30855722-F6418336-1DA0-47E6-9F63-32C6D59F2C8BQ31106864-A2C56676-A6CC-4BBF-A99C-022EF8EC1F32Q32944305-215B2785-45C9-49D9-9804-9176EA4ED238Q33659702-AB713438-DDBA-4FC3-8310-F07BF91798C6Q33734398-09980D4B-D86F-44D8-A206-85A343C64ECFQ33793138-3123DA0E-4E7E-457C-B2B4-5B310052C5BDQ33794952-FDAA4D52-6AE1-4CEA-BC71-E4FA1410F83EQ33837025-9D2E8EA5-DBCD-470A-9045-34DA6B1217E4Q33858214-57EE0E8B-8632-4420-B463-5D119FA3CCB3Q34073756-D6855572-EE38-4EAB-BCC5-2309AF5F0BD2Q34316563-A46F2D39-3761-49BF-B9F2-40AC855F5242Q34702892-345E90B5-94C1-4678-B9E8-F6A3A8268420Q34721475-60FB3E36-E8EA-4C49-95E3-28F137EC39A8Q34939176-5578040A-BE2F-4BC4-B0C4-66E01C62BD81Q35268464-1900C6F8-F129-423D-9BAD-A88BBAD96953Q35416385-5D878075-A313-49CF-8DF9-33228E3EA466Q35536686-6E88AAFE-B354-4E2E-8DE0-AC3A02FED7FDQ35569270-052515F1-E0B0-457A-9355-44FDBB79AB82Q35677184-E8975342-69C6-408C-BC37-B8026A71691CQ35728244-7654794D-F33D-4BFE-89D2-EF3AA8EA90D8Q35784145-4DB8E212-7C8B-4313-A771-EF5ACC0253C8Q36104993-81047ECA-50DD-499C-9B45-E40D158EEB36
P2860
Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Better safe than sorry: Unders ...... d for biomedical applications.
@en
Better safe than sorry: Unders ...... d for biomedical applications.
@nl
type
label
Better safe than sorry: Unders ...... d for biomedical applications.
@en
Better safe than sorry: Unders ...... d for biomedical applications.
@nl
altLabel
Better safe than sorry: Unders ...... ed for biomedical applications
@en
prefLabel
Better safe than sorry: Unders ...... d for biomedical applications.
@en
Better safe than sorry: Unders ...... d for biomedical applications.
@nl
P1476
Better safe than sorry: Unders ...... d for biomedical applications.
@en
P2093
Alfonso E Garcia-Bennett
P304
P356
10.1016/J.ADDR.2009.11.008
P407
P50
P577
2009-11-10T00:00:00Z